NEW YORK, Sept. 10, 2020 /PRNewswire/ --
Aimmune Therapeutics, Inc. (NASDAQ: AIMT)
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of AIMT to Sociétés des Produits Nestlé, S.A. for $34.50 per share.
If you are a AIMT investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Akcea Therapeutics, Inc. (NASDAQ: AKCA)
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of AKCA to Ionis for $18.15 per share in cash.
If you are a AKCA investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
BMC Stock Holdings, Inc. (NASDAQ: BMCH) - Builders FirstSource, Inc. (NASDAQ: BLDR)
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of BMCH to Builders FirstSource, Inc.
If you are a BMCH or BLDR investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Broadway Financial Corporation (NASDAQ: BYFC)
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of BYFC to CFBanc Corporation.
If you are a BYFC investor, and would like additional information about our investigation, please complete the Information Request Form or e-mail at info@jlclasslaw.com.
Cancer Genetics, Inc. (NASDAQ: CGIX)
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the merger of CGIX with StemoniX, Inc.
If you are a CGIX investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Proteostasis Therapeutics, Inc. (NASDAQ: PTI)
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the merger of PTI with Yumanity Therapeutics.
If you are a PTI investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Rosetta Stone Inc. (NYSE:RST)
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of RST to Cambium Learning Group for $30 per share.
If you are a RST investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Yintech Investment Holdings Limited (NASDAQ: YIN)
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of YIN to members of YIN management.
If you are a YIN investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
ATTORNEY ADVERTISING.© 2020 Lifshitz Law Firm, P.C. The law firm responsible for this advertisement is Lifshitz Law Firm, P.C., 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Contact:
Joshua M. Lifshitz, Esq.
Lifshitz Law Firm, P.C.
Phone: 516-493-9780
Facsimile: 516-280-7376
Email: info@jlclasslaw.com
View original content:http://www.prnewswire.com/news-releases/lifshitz-law-firm-pc-announces-investigation-of-aimmune-therapeutics-inc-akcea-therapeutics-inc--bmc-stock-holdings-inc-builders-firstsource-inc-broadway-financial-corporation-cancer-genetics-inc--proteostasis-t-301128074.html
SOURCE Lifshitz & Miller Law Firm